Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Reaxys User Day 2022: Sharing insights and tips for streamlining the chemist workflow
Posted on June 14th, 2022 by Louise Springthorpe in Chemistry
Whether you are an academic seeking a potential next-level cancer treatment, a pharma company charting out the competitive landscape, or a researcher wanting to stay on top of the latest bioactivity and pharmacological data relevant to your specialty, the Reaxys User Day 2022 proved a cornucopia of tips and tricks for chemists on how to streamline their workflow. Now, in case you missed the big day, these presentations are now online. Watch and learn.
(more…)Reaxys Prize Winners Share Their Research Experiences and Advice
Posted on April 13th, 2021 by Ann-Marie Roche in Chemistry
If there is one thing we at Elsevier have learned over the last 10 years of hosting the Reaxys PhD Prize, it’s that there are many different paths to research success. We have seen incredible work from scientists coming from a variety of backgrounds and experiences, and that was again evident with our three winning finalists for the 2020 Reaxys PhD Prize.
(more…)What Were the Biggest Advances in Life Sciences in 2020?
Posted on February 8th, 2021 by Ann-Marie Roche in Pharma R&D
As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why we asked members of Elsevier’s Life Sciences team what they felt were among the most noteworthy advances in the life sciences in 2020.
(more…)Pharma Industry Conferences Have Gone Online – Will They Stay There?
Posted on December 3rd, 2020 by Xuanyan Xu in Pharma R&D
Back in 2014, writer Nick de Cent posed the question Is it time for the conference to go virtual? He interviewed digital healthcare consultant Len Starnes, who argued that bringing pharma and healthcare conferences online could be beneficial in many ways, most notably in expanding participation. Six years later, and COVID-19 forced the issue, prompting many conferences to go fully virtual.
(more…)
